European expansion Sanity Group is rapidly expanding its European footprint across Germany, Switzerland, Poland, the UK, and Czechia, signaling a growing appetite for partnerships and distribution channels in multiple regulatory environments.

Strategic partnerships Recent and ongoing partnerships with Curaleaf International and Astrasana Holding AG indicate a strong channel strategy and openness to co-development and distribution arrangements that can be leveraged for joint product launches and cross-border reach.

Cannabinoid portfolio With activities spanning medicinal cannabis and consumer wellbeing products, there are opportunities to upsell contract manufacturing, private-label development, and formulation collaborations for Europe-wide distribution.

Invested scale Significant funding and notable investor interest (including $15M+ in 2024 and a $21M investment in 2024) point to a growing organization capable of scaling manufacturing, regulatory support, and regional compliance, ideal for manufacturing partners and technology enablement.

Tech and compliance readiness A tech stack including AWS, Optimizely, and enterprise-grade web infrastructure, combined with European-focused operations, suggests readiness for digital collaboration, data-driven supply chain, and scalable e-commerce or B2B platforms with potential integration opportunities.